Could sound waves boost brain health in Alzheimer's?
NCT ID NCT07143734
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests a non-invasive device that sends low-energy pulses to the brain, aiming to improve thinking and behavior in people with early Alzheimer's. Forty adults aged 60-90 will receive either real or sham (fake) pulses over several weeks. Researchers will measure changes in memory, mood, and daily function to see if the treatment is safe and helpful.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
transcranial pulse stimulation (TPS) device
What this could lead to
If it works, this could point toward a non-invasive, drug-free way to slow cognitive decline and reduce neuropsychiatric symptoms in early Alzheimer's disease.
What could go wrong
This is a very small pilot study (40 people) testing a new device approach. The effect may be small or no better than placebo, and long-term benefits or risks are unknown.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DEMENTIA (AD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Medicine & Therapeutics, Faculty of Medicine, The Chinese UNiversity of Hong Kong
RECRUITINGHong Kong, Hong Kong
Contact Phone: •••-•••-•••• Email: •••••@•••••